Cypre's blog to discuss the latest movements in science.
April 13, 2023: Cypre and Charles River publish a peer-reviewed manuscript detailing the Cypre 3D tumor platform, titled "A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno-Therapies"
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
